The indole nucleoside antibiotics neosidomycin 5 and SF-2140 3 have been synthesized. Methyl 4-deoxy-2,3-O-isopropylidene-a-D-lyxo-hexopyranoside 8 was converted into methyl 1-chloro-1,4-dideoxy-2.3-di-O-pivaloyl-a-D- lyxo-hexopyranuronate 33 in five steps. Silver (I)-catalysed coupling of compound 33 with 3-(cyanomethyl)indole 20 gave stereoselectively an a-nucleoside which was converted into methyl 1-[3-(carbamoylmethyl)indol- 1-yl]-1,4-dideoxy-a-D-lyxo-hexopyranuronate (neosidomycin, 5). Coupling of compound 33 to 3-cyanomethyl-4-methoxyindole 23 by the sodium salt procedure, and subsequent deacylation, gave methyl 1-(3-cyanomethyl-4-methoxyindol-1-yl)-1, 4-dideoxy-a-D-lyxo-hexopyranuronate (SF-2140, 3). Neosidomycin, SF-2140, and their O-acyl derivatives adopt a conformation which differs from that of 1-(6-O-benzoyl-4-deoxy-2,3-O-pivaloyl-a-D-lyxo-hexopyranosyl) -3-(cyanomethyl)indole 29, in which the methyl uronate grouping of the antibiotics is present at a lower oxidation level.
|Number of pages||10|
|Journal||Journal of the Chemical Society, Perkin Transactions 1|
|Publication status||Published - 1994|